Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and herpes simplex virus type 2

Sexually Transmitted Diseases

Volumn 28, Issue 8, 2001, Pages 484-491

  Piret, Jocelyne ^a   Gagné, Nathalie ^a   Perron, Sylvie ^a   Désormeaux, André ^a   Tremblay, Michel J ^a   Gourde, Pierrette ^a   Omar, Rabeea F ^a   Bergeron, Michel G ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIINFECTIVE AGENT; BACTERICIDE; PHOSPHATE; POLYMER;

ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; EPIDEMIC; GEL; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION CONTROL; INFECTION PREVENTION; ISOTOPE LABELING; NONHUMAN; OINTMENT; SEXUALLY TRANSMITTED DISEASE; VIRUS INACTIVATION;

EID: 0034903840     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200108000-00012     Document Type: Article

References (38)

1. Challenges for the development of female-controlled vaginal microbicides
2. The effectiveness of barrier methods of contraception in preventing the spread of HIV
3. Observations from the CDC: The urgent need for new HIV/STD prevention options for women
4. Contraceptives of the future in the light of HIV infection
5. HIV prevention: The need for methods women can use
6. The need for vaginal microbicides with antiviral specificity
7. Inactivation of herpes simplex viruses by nonionic surfactants
8. Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro
9. Comparative in vitro study of contraceptive agents with anti-HIV activity: Gramicidin, nonoxynol-9, and gossypol
10. The protective effect of nonoxynol-9 against HIV infection
11. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in vitro
12. In vitro evaluations of condoms with and without nonoxynol-9 as physical and chemical barriers against Chlamydia trachomatis, Herpes simplex virus type 2, and human immunodeficiency virus
13. Inactivation of HIV by nonoxynol-9
14. In vitro inactivation of HIV-1 by contraceptive sponge containing non-oxynol-9
15. Advances in topical microbicides
16. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes
17. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases
18. Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects
19. The effect of frequent nonoxynol-9 use on the vaginal and cervical mucosa
20. A dosing study of nonoxynol-9 and genital irritation
21. Topical microbicides for the prevention of STDs/HIV
22. Topical microbicides: Current status and research considerations for adolescent girls
23. Efficacies of topical formulations of foscarnet and acyclovir and of 5% acyclovir ointment (Zovirax) in a murine model of cutaneous Herpes simplex virus type 1 infection
24. Monoclonal antibody and enzymatic profiles of human malignant T lymphoid cells and derived cell lines
25. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): Failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1
26. A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line
27. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay
28. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses
29. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
30. Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1
31. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity
32. The epidemiology of the acquired immunodeficiency syndrome in the 1990s
33. Interrelationship between gender relations and the HIV/AIDS epidemic: Some possible considerations for policies and programmes
34. Efficacy of gel formulations containing free or liposomal foscarnet in a murine model of cutaneous Herpes simplex type 1 infection
35. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9
36. Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases
37. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses
38. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses